Insmed
INSM
165 hedge funds and large institutions have $1.56B invested in Insmed in 2020 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 49 increasing their positions, 59 reducing their positions, and 41 closing their positions.
250% more call options, than puts
Call options by funds: $10.8M | Put options by funds: $3.08M
1.27% less ownership
Funds ownership: 110.06% → 108.79% (-1.3%)
6% less funds holding
Funds holding: 176 → 165 (-11)
17% less repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 59
17% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 41
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
33% less capital invested
Capital invested by funds: $2.35B → $1.56B (-$784M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$73.2M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$30.5M |
| 3 |
Holocene Advisors
New York
|
+$20.4M |
| 4 |
William Blair Investment Management
Chicago,
Illinois
|
+$17M |
| 5 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$16.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$67.2M |
| 2 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$19.1M |
| 3 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$18.8M |
| 4 |
D.E. Shaw & Co
New York
|
-$17.9M |
| 5 |
FCMI
Foresite Capital Management IV
Larkspur,
California
|
-$17.8M |
INSM Hedge Fund Activity: Q1 2020 in Review
165 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Insmed (INSM) for Q1 2020, worth a combined $1.56B — down 33% from $2.35B a quarter earlier.
Sellers outnumbered buyers: 41 funds closed out of INSM and 34 opened new positions — a net loss of 7 holders — while 59 trimmed existing stakes and 49 added.
The largest buyer was Point72 Asset Management, adding an estimated $73.2M. The largest seller was Janus Henderson Group, cutting an estimated $67.2M.
- 165 institutional investors held Insmed (INSM) as of Q1 2020, down from 176 in Q4 2019.
- Funds reported $1.56B of Insmed stock for Q1 2020, down 33% quarter-over-quarter.
- 34 funds opened new Insmed positions in Q1 2020 and 41 closed out, a net change of -7 holders.
- The largest Insmed buyer in Q1 2020 was Point72 Asset Management, an estimated $73.2M added.
- The largest Insmed seller in Q1 2020 was Janus Henderson Group, an estimated $67.2M sold.
Based on aggregated 13F filings for Q1 2020.